Literature DB >> 311606

Novel beta-lactamase from Branhamella catarrhalis.

A B Hoi-Dang, C Brive-Le Bouguenec, M Barthelemy, R Labia.   

Abstract

A strain of Branhamella catarrhalis isolated from sputum was shown to be resistant to penicillin and ampicillin. This strain produced a beta-lactamase which has been judged to be a novel enzyme, on the basis of substrat profil, isoelectric point and location of genetic determinant.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 311606

Source DB:  PubMed          Journal:  Ann Microbiol (Paris)        ISSN： 0300-5410


  23 in total

1.  Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.

Authors:  Franz-Josef Schmitz; Andreas Beeck; Mirella Perdikouli; Mechthild Boos; Susanne Mayer; Sybille Scheuring; Karl Köhrer; Jan Verhoef; Ad C Fluit
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

Review 2.  In vitro antibacterial activity and pharmacodynamics of new quinolones.

Authors:  A Dalhoff; F-J Schmitz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-04-01       Impact factor: 3.267

3.  Gram-negative Diplococcal Respiratory Infections.

Authors:  Nargis Naheed; Maqsood Alam; Larry I. Lutwick
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

4.  Genetic basis of tetracycline resistance in Moraxella (Branhamella) catarrhalis.

Authors:  M C Roberts; B A Brown; V A Steingrube; R J Wallace
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

5.  Impact on peritonsillar infections and microflora of phenoxymethylpenicillin alone versus phenoxymethylpenicillin in combination with metronidazole.

Authors:  K Tunér; C E Nord
Journal:  Infection       Date:  1986 May-Jun       Impact factor: 3.553

6.  Classification of beta-lactamases from Branhamella catarrhalis in relation to penicillinases produced by other bacterial species.

Authors:  R Labia; M Barthelemy; C B Le Bouguennec; A Buu Hoi-Dang Van
Journal:  Drugs       Date:  1986       Impact factor: 9.546

7.  Purification and properties of a beta-lactamase produced by Branhamella catarrhalis.

Authors:  E Yokota; T Fujii; K Sato; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

8.  Biological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalis.

Authors:  Shengqing Yu; Xin-Xing Gu
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

9.  BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.

Authors:  R J Wallace; V A Steingrube; D R Nash; D G Hollis; C Flanagan; B A Brown; A Labidi; R E Weaver
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

10.  Bronchopulmonary infection due to Branhamella catarrhalis.

Authors:  D T McLeod; F Ahmad; J T Power; M A Calder; A Seaton
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.